Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$156M Sell
300,854
-767,517
-72% -$389M 1.51% 19
2026
Q1
$530M Buy
+1,068,371
New +$504M 5.88% 4
2023
Q2
Sell
-119,255
Closed -$42.4M 24
2023
Q1
$42.4M Buy
+119,255
New +$39.9M 0.46% 24
2022
Q4
Sell
-1,094,168
Closed -$295M 25
2022
Q3
$295M Sell
1,094,168
-181,199
-14% -$52M 2.29% 19
2022
Q2
$367M Sell
1,275,367
-1,168,350
-48% -$365M 2.48% 16
2022
Q1
$781M Buy
2,443,717
+1,171,725
+92% +$362M 4.11% 10
2021
Q4
$441M Sell
1,271,992
-2,314,175
-65% -$750M 2.05% 17
2021
Q3
$1.05B Buy
3,586,167
+327,763
+10% +$99.6M 5% 6
2021
Q2
$942M Buy
3,258,404
+11,372
+0.4% +$3.32M 4.68% 9
2021
Q1
$910M Buy
3,247,032
+379,336
+13% +$98.4M 4.79% 9
2020
Q4
$756M Buy
2,867,696
+765,279
+36% +$188M 4.28% 10
2020
Q3
$501M Sell
2,102,417
-708,196
-25% -$172M 3.09% 16
2020
Q2
$596M Sell
2,810,613
-79,596
-3% -$15.4M 4.43% 10
2020
Q1
$500M Buy
+2,890,209
New +$570M 5.17% 10
2019
Q1
Sell
-3,006,048
Closed -$469M 28
2018
Q4
$469M Buy
+3,006,048
New +$475M 3.9% 12

Other funds holding LIN

John Armitage's LIN Position: Q2 2026 in Review

John Armitage reduced its Linde (LIN) stake by 72% in Q2 2026, selling an estimated $389M and leaving 300,854 shares worth $156M. The position accounts for 1.51% of the portfolio, ranked #19.

John Armitage first reported a position in LIN in Q4 2018 and has held it in 15 quarters since. The position peaked at $1.05B in Q3 2021. 2,331 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

  • John Armitage held 300,854 shares of Linde worth $156M as of Q2 2026.
  • John Armitage sold 767,517 Linde shares in Q2 2026, an estimated $389M.
  • Linde made up 1.51% of John Armitage's portfolio in Q2 2026, its #19 holding.
  • John Armitage first reported a position in Linde in Q4 2018 and has held it in 15 quarters since.
  • John Armitage's Linde position peaked at $1.05B in Q3 2021.
  • 2,331 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Egerton Capital (UK)'s 13F filing for Q2 2026, filed 21 Jul 2026.